These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 17161122

  • 1. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P, Paavonen J, Heikinheimo O.
    Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
    [Abstract] [Full Text] [Related]

  • 2. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
    Heikinheimo O, Lehtovirta P, Suni J, Paavonen J.
    Hum Reprod; 2006 Nov; 21(11):2857-61. PubMed ID: 16880227
    [Abstract] [Full Text] [Related]

  • 3. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [Abstract] [Full Text] [Related]

  • 4. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D, Janssens D, Andrade A.
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [Abstract] [Full Text] [Related]

  • 5. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M, Odlind V.
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
    Andrade A, Wildemeersch D.
    Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC, Virtanen-Kari S.
    BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET, Yigit R, Molenberghs G, Straetmans D, Ombelet W.
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [Abstract] [Full Text] [Related]

  • 12. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW, Symonds IM, Tamizian O, Chaplain J, Mukhopadhyay S.
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [Abstract] [Full Text] [Related]

  • 13. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA, Farquhar CM, Sowter MC, Lethaby A, Sprecher M, Yu Y, Sadler LC, Brown P, Johnson N.
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [Abstract] [Full Text] [Related]

  • 14. Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)--a multicentre prospective study.
    Gemzell-Danielsson K, Inki P, Boubli L, O'Flynn M, Kunz M, Heikinheimo O.
    Hum Reprod; 2010 Feb; 25(2):354-9. PubMed ID: 19955104
    [Abstract] [Full Text] [Related]

  • 15. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D, Rowe PJ.
    Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
    [Abstract] [Full Text] [Related]

  • 16. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS, Reardon B, Arepally G.
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [Abstract] [Full Text] [Related]

  • 17. Progestin-releasing intrauterine systems and leiomyoma.
    Kaunitz AM.
    Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
    [Abstract] [Full Text] [Related]

  • 18. Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels.
    Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, DeSanctis Y, Jensen J.
    Contraception; 2012 Nov; 86(5):452-7. PubMed ID: 22959906
    [Abstract] [Full Text] [Related]

  • 19. The levonorgestrel intrauterine system: more than a contraceptive.
    Andersson K.
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():15-22. PubMed ID: 11336429
    [Abstract] [Full Text] [Related]

  • 20. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S, Galant C, Nisolle M, Ravet S, Munaut C, Marbaix E, Foidart JM, Frankenne F.
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.